Skip to main content
. 2015 Apr 27;10(4):e0124839. doi: 10.1371/journal.pone.0124839

Fig 2. Effect of HbAHP-25 on the viability of TZM-bl cells, VK2 cells, CEM-GFP cells and PBMCs.

Fig 2

Cells were treated with HbAHP-25 (4.4–1142.4µM) for 120 hrs. Percentage of viability was calculated with respect to control (not treated with HbAHP-25). 0.1% Triton X was used as a positive control. Values are the mean (± SD) of three replicates.